Efficacy of insulin glargine 300 U/ml in patients with type 2 diabetes insufficiently compensated by basal insulin therapy in the conditions of routine clinical practice in the Czech Republic

Abstract

The aim of the study was to evaluate the clinical efficacy of insulin glargine 300 U/ml (Gla-300) in the treatment of patients with type 2 diabetes (DM2) insufficiently compensated by basal insulin in the conditions of routine clinical practice in the Czech Republic (TOPAZ study).